Ambu As Stock Fundamentals

AMBFF Stock  USD 19.90  0.00  0.00%   
Ambu AS fundamentals help investors to digest information that contributes to Ambu A/S's financial success or failures. It also enables traders to predict the movement of Ambu Pink Sheet. The fundamental analysis module provides a way to measure Ambu A/S's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ambu A/S pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Ambu AS Company Current Valuation Analysis

Ambu A/S's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Ambu A/S Current Valuation

    
  3.73 B  
Most of Ambu A/S's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ambu AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Ambu AS has a Current Valuation of 3.73 B. This is 74.01% lower than that of the Biotechnology sector and 69.95% lower than that of the Health Care industry. The current valuation for all United States stocks is 77.54% higher than that of the company.

Ambu A/S Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ambu A/S's current stock value. Our valuation model uses many indicators to compare Ambu A/S value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ambu A/S competition to find correlations between indicators driving Ambu A/S's intrinsic value. More Info.
Ambu AS is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.60  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ambu AS is roughly  1.67 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ambu A/S's earnings, one of the primary drivers of an investment's value.

Ambu Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ambu A/S's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Ambu A/S could also be used in its relative valuation, which is a method of valuing Ambu A/S by comparing valuation metrics of similar companies.
Ambu AS is currently under evaluation in current valuation category among its peers.

Ambu Fundamentals

About Ambu A/S Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Ambu AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ambu A/S using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ambu AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Ambu AS develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. Ambu AS was founded in 1937 and is headquartered in Ballerup, Denmark. AMBU AS is traded on OTC Exchange in the United States.

Currently Active Assets on Macroaxis

Other Information on Investing in Ambu Pink Sheet

Ambu A/S financial ratios help investors to determine whether Ambu Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ambu with respect to the benefits of owning Ambu A/S security.